Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor version update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer was updated to Revision: v3.3.3 and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed. No changes to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding outage notice was removed from the page. This notice previously warned that information may not be up to date and that NIH operations could affect responses.SummaryDifference0.4%

- Check72 days agoChange DetectedNo additions or deletions were detected; the study overview, eligibility criteria, study plan, and contact information for NCT03879811 remain as shown.SummaryDifference0.4%

- Check101 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.